Newsletter
Every new paper in this field, in your inbox.
A comparative analysis of metabolic and bariatric surgery (MBS) versus glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy indicated that MBS significantly lowers the hazard of cardiovascular disease in patients with obesity. Specifically, MBS demonstrated a reduced risk for the primary composite outcome of cardiovascular disease…
A systematic review and meta-analysis of 19 studies involving 1,290 patients revealed that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) effectively address suboptimal initial clinical response and weight gain recurrence after bariatric surgery. Notable results included pooled total weight loss percentages of 9.24% for liraglutide, 11.38%…
A novel Diabetes Remission Index (DRI) and Weight Loss-Adjusted Diabetes Remission Index (W-DRI) were developed to predict remission rates for type 2 diabetes following metabolic and bariatric surgery. In internal validation, the DRI model achieved an AUC of 0.80 with a 44.7% remission rate, while…
Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and cirrhosis experience significantly lower long-term mortality rates after bariatric surgery, particularly with laparoscopic techniques. A study in California analyzed data from 91,708 patients, revealing that those who underwent bariatric surgery had a 5-year overall mortality rate…
The hiatal sling liver retraction technique has shown promising results in bariatric and upper gastrointestinal surgeries, significantly reducing liver enzyme elevation compared to the traditional Nathanson retractor. Among 1,874 surgeries, only two cases experienced difficulties, with no liver injuries or adverse effects reported. This technique…
The study analyzed 973,520 cases of metabolic and bariatric surgery, revealing that conditions such as GERD, COPD, smoking, and specific surgical procedures significantly heighten the risk of inpatient postoperative care (IP-POC) needs. Male patients exhibited increased severity but lower likelihood of complications, while Black and…
A meta-analysis of ten randomized controlled trials demonstrated that Roux-en-Y gastric bypass (RYGB) significantly enhances outcomes for patients with type 2 diabetes mellitus (T2DM). Key findings revealed improved compliance rates, higher remission rates, and reductions in glycated hemoglobin (HbA1c) and fasting blood glucose levels. Additionally,…
In a study comparing weight loss outcomes between sleeve gastrectomy (SG) and semaglutide in a minority population, SG demonstrated superior weight loss after 12 months. The cohort, primarily consisting of African American (67%) and Hispanic (21%) patients with a mean BMI of 55 kg/m², included…
Histological remission of metabolic dysfunction-associated steatohepatitis (MASH) and significant fibrosis enhances survival rates post-bariatric surgery. In a cohort of 3028 patients over a median follow-up of 10.1 years, those with persistent MASH or worsening fibrosis exhibited increased mortality, while those whose MASH resolved without fibrosis…
A meta-analysis revealed that sleeve gastrectomy (SG) significantly reduces the apnea-hypopnea index (AHI), body mass index (BMI), weight, and fat areas while enhancing forced vital capacity (FVC) and sleep metrics in patients with obesity and obstructive sleep apnea (OSA). Key post-surgical benefits included decreased arousal…
